Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Broder

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Treatment Reports|April 1, 1984
Cisplatin-induced autonomic neuropathyC S Rosenfeld, L E Broder
Medical and Pediatric Oncology|January 1, 1976
Pharmacokinetic considerations in the design of optimal chemotherapeutic regimens for the treatment of breast carcinoma: a comceptual approachL E Broder, P P Carbone
Journal of the National Cancer Institute|August 1, 1978
Influence of chemotherapeutic agents on chorionic gonadotropin-alpha subunit secretion in a human lung cancer cell line (ChaGo): discordance of cytotoxic and secretory effectsL E Broder, B D Weintraub, S W Rosen
Cancer|April 15, 1984
Lobular carcinoma of the breast metastatic to bone with unusual clinical, radiologic, and pathologic features mimicking osteopoikilosisL Ghandur-Mnaymneh, L E Broder, W A Mnaymneh
Cancer Letters|January 1, 1978
Vitamin A serum and dietary vitamin A intake in lung cancer patientsM H Cohen, A Primack, L E Broder, et al.
Chest|March 1, 1981
A controlled clinical trial testing two potentially non-cross-resistant chemotherapeutic regimens in small-cell carcinoma of the lungL E Broder, O S Selawry, K N Charyulu, et al.
Cancer Chemotherapy Reports|September 1, 1975
Phase I study of thalicarpine (NAC-68075), a plant alkaloid of noval structureP J Creaven, M H Cohen, O S Selawry, et al.
Cancer|July 1, 1977
Placental proteins and their subunits as tumor markers in prostatic carcinomaL E Broder, B D Weintraub, S W Rosen, et al.
American Journal of Clinical Oncology|December 1, 1992
A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patientsL E Broder, K S Sridhar, O S Selawry, et al.
Cancer|August 1, 1979
Calcitonin as a marker for bronchogenic cancer: a prospective studyO L Silva, L E Broder, J L Doppman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Treatment Reports|April 1, 1984
Cisplatin-induced autonomic neuropathyC S Rosenfeld, L E Broder
Medical and Pediatric Oncology|January 1, 1976
Pharmacokinetic considerations in the design of optimal chemotherapeutic regimens for the treatment of breast carcinoma: a comceptual approachL E Broder, P P Carbone
Journal of the National Cancer Institute|August 1, 1978
Influence of chemotherapeutic agents on chorionic gonadotropin-alpha subunit secretion in a human lung cancer cell line (ChaGo): discordance of cytotoxic and secretory effectsL E Broder, B D Weintraub, S W Rosen
Cancer|April 15, 1984
Lobular carcinoma of the breast metastatic to bone with unusual clinical, radiologic, and pathologic features mimicking osteopoikilosisL Ghandur-Mnaymneh, L E Broder, W A Mnaymneh
Cancer Letters|January 1, 1978
Vitamin A serum and dietary vitamin A intake in lung cancer patientsM H Cohen, A Primack, L E Broder, et al.
Chest|March 1, 1981
A controlled clinical trial testing two potentially non-cross-resistant chemotherapeutic regimens in small-cell carcinoma of the lungL E Broder, O S Selawry, K N Charyulu, et al.
Cancer Chemotherapy Reports|September 1, 1975
Phase I study of thalicarpine (NAC-68075), a plant alkaloid of noval structureP J Creaven, M H Cohen, O S Selawry, et al.
Cancer|July 1, 1977
Placental proteins and their subunits as tumor markers in prostatic carcinomaL E Broder, B D Weintraub, S W Rosen, et al.
American Journal of Clinical Oncology|December 1, 1992
A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patientsL E Broder, K S Sridhar, O S Selawry, et al.
Cancer|August 1, 1979
Calcitonin as a marker for bronchogenic cancer: a prospective studyO L Silva, L E Broder, J L Doppman, et al.
Pageof 2